Bruker Corporation (BRKR)
USD 36.32
(-3.56%)
USD 36.32
(-3.56%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 1.51 Billion USD | 16.17% |
| 2022 | 1.3 Billion USD | 7.94% |
| 2021 | 1.2 Billion USD | 28.71% |
| 2020 | 939.8 Million USD | -5.58% |
| 2019 | 995.3 Million USD | 10.59% |
| 2018 | 900 Million USD | 10.7% |
| 2017 | 813 Million USD | 9.49% |
| 2016 | 742.5 Million USD | 4.78% |
| 2015 | 708.6 Million USD | -7.17% |
| 2014 | 763.3 Million USD | -5.2% |
| 2013 | 805.2 Million USD | -3.15% |
| 2012 | 831.4 Million USD | 10.49% |
| 2011 | 752.5 Million USD | 24.17% |
| 2010 | 606 Million USD | 16.85% |
| 2009 | 518.6 Million USD | 2.69% |
| 2008 | 505 Million USD | 99.5% |
| 2007 | 253.13 Million USD | 26.99% |
| 2006 | 199.33 Million USD | 58.44% |
| 2005 | 125.8 Million USD | 6.19% |
| 2004 | 118.47 Million USD | 2.27% |
| 2003 | 115.84 Million USD | 91.49% |
| 2002 | 60.49 Million USD | 23.2% |
| 2001 | 49.1 Million USD | 19.72% |
| 2000 | 41.01 Million USD | 12.19% |
| 1999 | 36.55 Million USD | -13.38% |
| 1998 | 42.2 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 356.5 Million USD | -16.76% |
| 2024 Q3 | 410.2 Million USD | 5.31% |
| 2024 Q2 | 389.5 Million USD | 9.26% |
| 2023 Q2 | 340.5 Million USD | -5.34% |
| 2023 FY | 1.51 Billion USD | 16.17% |
| 2023 Q1 | 359.7 Million USD | -1.69% |
| 2023 Q4 | 428.3 Million USD | 11.89% |
| 2023 Q3 | 382.8 Million USD | 12.42% |
| 2022 FY | 1.3 Billion USD | 7.94% |
| 2022 Q1 | 306.3 Million USD | -10.33% |
| 2022 Q2 | 298.2 Million USD | -2.64% |
| 2022 Q3 | 335.3 Million USD | 12.44% |
| 2022 Q4 | 365.9 Million USD | 9.13% |
| 2021 FY | 1.2 Billion USD | 28.71% |
| 2021 Q3 | 308.7 Million USD | 10.01% |
| 2021 Q2 | 280.6 Million USD | 0.68% |
| 2021 Q1 | 278.7 Million USD | -10.96% |
| 2021 Q4 | 341.6 Million USD | 10.66% |
| 2020 Q3 | 248.3 Million USD | 33.35% |
| 2020 FY | 939.8 Million USD | -5.58% |
| 2020 Q4 | 313 Million USD | 26.06% |
| 2020 Q2 | 186.2 Million USD | -3.17% |
| 2020 Q1 | 192.3 Million USD | -35.1% |
| 2019 FY | 995.3 Million USD | 10.59% |
| 2019 Q4 | 296.3 Million USD | 16.7% |
| 2019 Q1 | 214.7 Million USD | -21.3% |
| 2019 Q2 | 230.4 Million USD | 7.31% |
| 2019 Q3 | 253.9 Million USD | 10.2% |
| 2018 Q1 | 199.4 Million USD | -21.87% |
| 2018 Q2 | 205.2 Million USD | 2.91% |
| 2018 FY | 900 Million USD | 10.7% |
| 2018 Q4 | 272.8 Million USD | 22.55% |
| 2018 Q3 | 222.6 Million USD | 8.48% |
| 2017 Q1 | 176.4 Million USD | -19.96% |
| 2017 FY | 813 Million USD | 9.49% |
| 2017 Q3 | 198 Million USD | 7.96% |
| 2017 Q4 | 255.2 Million USD | 28.89% |
| 2017 Q2 | 183.4 Million USD | 3.97% |
| 2016 FY | 742.5 Million USD | 4.78% |
| 2016 Q4 | 220.4 Million USD | 19.01% |
| 2016 Q3 | 185.2 Million USD | 8.88% |
| 2016 Q2 | 170.1 Million USD | 1.98% |
| 2016 Q1 | 166.8 Million USD | -21.13% |
| 2015 Q3 | 167.5 Million USD | -1.12% |
| 2015 FY | 708.6 Million USD | -7.17% |
| 2015 Q4 | 211.5 Million USD | 26.27% |
| 2015 Q1 | 160.2 Million USD | -25.76% |
| 2015 Q2 | 169.4 Million USD | 5.74% |
| 2014 Q1 | 179.7 Million USD | -23.82% |
| 2014 Q3 | 167.3 Million USD | -16.56% |
| 2014 Q4 | 215.8 Million USD | 28.99% |
| 2014 FY | 763.3 Million USD | -5.2% |
| 2014 Q2 | 200.5 Million USD | 11.57% |
| 2013 FY | 805.2 Million USD | -3.15% |
| 2013 Q4 | 235.9 Million USD | 22.1% |
| 2013 Q3 | 193.2 Million USD | -4.17% |
| 2013 Q2 | 201.6 Million USD | 15.53% |
| 2013 Q1 | 174.5 Million USD | -27.95% |
| 2012 FY | 831.4 Million USD | 10.49% |
| 2012 Q1 | 190.4 Million USD | -12.54% |
| 2012 Q2 | 188.2 Million USD | -1.16% |
| 2012 Q3 | 210.6 Million USD | 11.9% |
| 2012 Q4 | 242.2 Million USD | 15.0% |
| 2011 FY | 752.5 Million USD | 24.17% |
| 2011 Q1 | 165.1 Million USD | -16.24% |
| 2011 Q3 | 189.4 Million USD | 3.16% |
| 2011 Q2 | 183.6 Million USD | 11.21% |
| 2011 Q4 | 217.7 Million USD | 14.94% |
| 2010 Q3 | 146.9 Million USD | 8.25% |
| 2010 Q2 | 135.7 Million USD | 7.44% |
| 2010 FY | 606 Million USD | 16.85% |
| 2010 Q4 | 197.1 Million USD | 34.17% |
| 2010 Q1 | 126.3 Million USD | -31.91% |
| 2009 Q1 | 102.7 Million USD | -32.95% |
| 2009 FY | 518.6 Million USD | 2.69% |
| 2009 Q4 | 185.5 Million USD | 55.62% |
| 2009 Q3 | 119.2 Million USD | 7.19% |
| 2009 Q2 | 111.2 Million USD | 8.28% |
| 2008 FY | 505 Million USD | 99.5% |
| 2008 Q4 | 153.16 Million USD | 39.15% |
| 2008 Q3 | 110.07 Million USD | -14.5% |
| 2008 Q2 | 128.73 Million USD | 13.8% |
| 2008 Q1 | 113.12 Million USD | 32.09% |
| 2007 Q1 | 52.62 Million USD | -16.69% |
| 2007 Q2 | 53.03 Million USD | 0.77% |
| 2007 FY | 253.13 Million USD | 26.99% |
| 2007 Q3 | 61.83 Million USD | 16.6% |
| 2007 Q4 | 85.64 Million USD | 38.51% |
| 2006 Q2 | 33.96 Million USD | 3.08% |
| 2006 Q1 | 32.94 Million USD | -1.54% |
| 2006 FY | 199.33 Million USD | 58.44% |
| 2006 Q3 | 46.18 Million USD | 35.98% |
| 2006 Q4 | 63.17 Million USD | 36.79% |
| 2005 FY | 125.8 Million USD | 6.19% |
| 2005 Q2 | 30.54 Million USD | -2.66% |
| 2005 Q1 | 31.37 Million USD | 5.2% |
| 2005 Q3 | 30.41 Million USD | -0.41% |
| 2005 Q4 | 33.46 Million USD | 10.01% |
| 2004 Q1 | 32.47 Million USD | 2.18% |
| 2004 Q3 | 31.73 Million USD | 21.82% |
| 2004 Q4 | 29.82 Million USD | -6.0% |
| 2004 Q2 | 26.04 Million USD | -19.78% |
| 2004 FY | 118.47 Million USD | 2.27% |
| 2003 Q2 | 16.09 Million USD | -6.8% |
| 2003 Q1 | 17.27 Million USD | -0.59% |
| 2003 Q4 | 31.78 Million USD | 11.92% |
| 2003 Q3 | 28.39 Million USD | 76.41% |
| 2003 FY | 115.84 Million USD | 91.49% |
| 2002 Q1 | 13.7 Million USD | 3.64% |
| 2002 FY | 60.49 Million USD | 23.2% |
| 2002 Q4 | 17.37 Million USD | 12.03% |
| 2002 Q3 | 15.5 Million USD | 11.54% |
| 2002 Q2 | 13.9 Million USD | 1.44% |
| 2001 Q1 | 11.47 Million USD | -4.83% |
| 2001 FY | 49.1 Million USD | 19.72% |
| 2001 Q4 | 13.22 Million USD | 5.48% |
| 2001 Q3 | 12.54 Million USD | 5.73% |
| 2001 Q2 | 11.86 Million USD | 3.36% |
| 2000 Q2 | 9.76 Million USD | 10.28% |
| 2000 Q1 | 8.85 Million USD | 0.0% |
| 2000 Q4 | 12.05 Million USD | 7.98% |
| 2000 Q3 | 11.16 Million USD | 14.32% |
| 2000 FY | 41.01 Million USD | 12.19% |
| 1999 FY | 36.55 Million USD | -13.38% |
| 1998 FY | 42.2 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 2.55 Million USD | -59382.353% |
| BrainsWay Ltd. | 23.09 Million USD | -6468.793% |
| Cerus Corporation | 86.4 Million USD | -1655.556% |
| Envoy Medical, Inc. | -473 Thousand USD | 320776.533% |
| electroCore, Inc. | 13.22 Million USD | -11368.32% |
| Helius Medical Technologies, Inc. | 61 Thousand USD | -2486457.377% |
| IceCure Medical Ltd | 1.3 Million USD | -116576.923% |
| Inogen, Inc. | 126.69 Million USD | -1097.168% |
| OrthoPediatrics Corp. | 111.25 Million USD | -1263.379% |
| Lucid Diagnostics Inc. | -6.05 Million USD | 25171.074% |
| Monogram Orthopaedics, Inc. | -47.33 Thousand USD | 3204426.517% |
| MaxCyte, Inc. | 36.54 Million USD | -4050.386% |
| NeuroOne Medical Technologies Corporation | 456.51 Thousand USD | -332154.878% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -1783111.85% |
| Orthofix Medical Inc. | 486.27 Million USD | -211.924% |
| PAVmed Inc | -3.96 Million USD | 38325.806% |
| Rapid Micro Biosystems, Inc. | -5.48 Million USD | 27753.601% |
| RxSight, Inc. | 53.76 Million USD | -2721.166% |
| Sight Sciences, Inc. | 69.17 Million USD | -2092.7% |
| SI-BONE, Inc. | 109.42 Million USD | -1286.218% |
| TELA Bio, Inc. | 40.11 Million USD | -3681.412% |
| Treace Medical Concepts, Inc. | 151.93 Million USD | -898.309% |
| Vivos Therapeutics, Inc. | 8.27 Million USD | -18238.774% |
| Acutus Medical, Inc. | -3.13 Million USD | 48451.929% |
| Talis Biomedical Corporation | 371 Thousand USD | -408740.97% |
| Spectral AI, Inc. | 7.88 Million USD | -19148.731% |
| Nano-X Imaging Ltd. | -6.59 Million USD | 23109.709% |
| CVRx, Inc. | 33.03 Million USD | -4490.938% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 739.52 Thousand USD | -205004.351% |
| Bioventus Inc. | 328.19 Million USD | -362.167% |
| Venus Concept Inc. | 52.16 Million USD | -2807.585% |
| TriSalus Life Sciences, Inc. | 15.9 Million USD | -9436.024% |
| LivaNova PLC | 771.25 Million USD | -96.668% |
| 908 Devices Inc. | 25.32 Million USD | -5890.048% |
| Alphatec Holdings, Inc. | 310.2 Million USD | -388.97% |
| Nemaura Medical Inc. | -1.47 Million USD | 102836.942% |
| NeuroPace, Inc. | 48.12 Million USD | -3051.989% |
| LENSAR, Inc. | 21.1 Million USD | -7086.242% |
| Apyx Medical Corporation | 14.12 Million USD | -10640.688% |
| Cutera, Inc. | 41.49 Million USD | -3555.468% |
| STRATA Skin Sciences, Inc. | 18.46 Million USD | -8116.24% |
| BioSig Technologies, Inc. | 18 Thousand USD | -8426566.667% |
| Anika Therapeutics, Inc. | 103.08 Million USD | -1371.364% |
| ClearPoint Neuro, Inc. | 13.61 Million USD | -11041.472% |
| Integra LifeSciences Holdings Corporation | 888.39 Million USD | -70.735% |
| Axonics, Inc. | 274.55 Million USD | -452.46% |
| Outset Medical, Inc. | 29 Million USD | -5130.345% |
| IRIDEX Corporation | 21.8 Million USD | -6855.565% |
| PROCEPT BioRobotics Corporation | 71.04 Million USD | -2034.865% |
| IRadimed Corporation | 50.15 Million USD | -2924.028% |
| Tivic Health Systems, Inc. | 287 Thousand USD | -528401.742% |
| INVO Bioscience, Inc. | 1.08 Million USD | -139550.763% |
| Telesis Bio, Inc. | 16.95 Million USD | -8848.673% |
| Viemed Healthcare, Inc. | 112.78 Million USD | -1244.884% |
| Varex Imaging Corporation | 256.9 Million USD | -490.424% |
| Quipt Home Medical Corp. | 163.84 Million USD | -825.753% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 373696.059% |
| Pulmonx Corporation | 50.75 Million USD | -2888.651% |
| Dynatronics Corporation | 7.63 Million USD | -19766.462% |
| Modular Medical, Inc. | -768 Thousand USD | 197600.0% |
| ReShape Lifesciences Inc. | 5.54 Million USD | -27239.582% |
| Semler Scientific, Inc. | 61.2 Million USD | -2378.431% |
| InMode Ltd. | 411.34 Million USD | -268.746% |
| Cytosorbents Corporation | 22.39 Million USD | -6673.841% |
| DexCom, Inc. | 2.28 Billion USD | 33.732% |
| Align Technology, Inc. | 2.71 Billion USD | 44.209% |
| Viveve Medical, Inc. | 620 Thousand USD | -244545.161% |
| ZimVie Inc. | 290.38 Million USD | -422.345% |
| Movano Inc. | -158 Thousand USD | 960100.0% |
| Cytek Biosciences, Inc. | 109.42 Million USD | -1286.142% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -1783111.85% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 367.69 Million USD | -312.521% |
| Profound Medical Corp. | 4.51 Million USD | -33501.97% |
| Insulet Corporation | 1.15 Billion USD | -30.77% |
| enVVeno Medical Corporation | -546 Thousand USD | 277902.198% |
| Surmodics, Inc. | 93.05 Million USD | -1530.056% |
| iCAD, Inc. | 14.53 Million USD | -10334.783% |
| Nuwellis, Inc. | 4.98 Million USD | -30339.494% |
| Biotricity, Inc. | 8.35 Million USD | -18051.616% |
| iRhythm Technologies, Inc. | 331.8 Million USD | -357.135% |
| Aethlon Medical, Inc. | -359.05 Thousand USD | 422539.891% |
| InspireMD, Inc. | 1.8 Million USD | -83840.232% |
| PAVmed Inc. | -3.96 Million USD | 38325.806% |
| BIOLASE, Inc. | 16.72 Million USD | -8969.6% |
| Beyond Air, Inc. | -1.3 Million USD | 116152.028% |
| FONAR Corporation | 45.14 Million USD | -3260.209% |
| AxoGen, Inc. | 127.87 Million USD | -1086.168% |
| Vivani Medical, Inc. | -357 Thousand USD | 424973.95% |
| Tactile Systems Technology, Inc. | 195.13 Million USD | -677.316% |
| Inari Medical, Inc. | 434.56 Million USD | -249.039% |
| UFP Technologies, Inc. | 112.22 Million USD | -1251.571% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 12.51 Thousand USD | -12115883.705% |
| Tenon Medical, Inc. | 1.24 Million USD | -122124.013% |
| Autonomix Medical, Inc. Common Stock | -81 Thousand USD | 1872692.593% |
| Co-Diagnostics, Inc. | 2.62 Million USD | -57636.91% |
| AdaptHealth Corp. | 479.56 Million USD | -216.287% |
| Sintx Technologies, Inc. | 1.84 Million USD | -82200.597% |
| NanoVibronix, Inc. | 1.53 Million USD | -98585.751% |
| Quanterix Corporation | 70.64 Million USD | -2047.043% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 373696.059% |
| Sensus Healthcare, Inc. | 14.06 Million USD | -10688.051% |
| Pacific Biosciences of California, Inc. | 52.78 Million USD | -2773.816% |
| TransMedics Group, Inc. | 154.09 Million USD | -884.341% |
| ReWalk Robotics Ltd. | 4.45 Million USD | -33962.43% |
| NeuroMetrix, Inc. | 3.94 Million USD | -38325.166% |
| Hyperfine, Inc. | 4.75 Million USD | -31785.642% |
| Establishment Labs Holdings Inc. | 106.97 Million USD | -1317.875% |
| Biomerica, Inc. | 611 Thousand USD | -248148.773% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 41.68 Million USD | -3538.511% |
| Bluejay Diagnostics, Inc. | -780.95 Thousand USD | 194323.739% |
| Silk Road Medical, Inc | 127.08 Million USD | -1093.522% |